THE PROGNOSTIC-SIGNIFICANCE OF THE HALF-LIFE OF SERUM CA-125 IN PATIENTS RESPONDING TO CHEMOTHERAPY FOR EPITHELIAL OVARIAN-CARCINOMA

被引：62
|
作者：
HAWKINS, RE
ROBERTS, K
WILTSHAW, E
MUNDY, J
FRYATT, IJ
MCCREADY, VR
机构：
[1] ROYAL MARSDEN HOSP,DEPT MED,FULHAM RD,LONDON SW3 6JJ,ENGLAND
[2] ROYAL MARSDEN HOSP,DEPT NUCL MED,LONDON SW3 6JJ,ENGLAND
来源：
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1989年 / 96卷 / 12期
关键词：
D O I：
10.1111/j.1471-0528.1989.tb06301.x
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1395 / 1399
页数：5
相关论文
共 50 条
  • [41] CLINICAL SIGNIFICANCE OF SERUM CA125 AND ITS HALF-LIFE ANALYSIS IN DIAGNOSIS AND PROGNOSIS OF OVARIAN CANCER
    Li, Z.
    Peng, Y.
    Cai, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [42] PREDICTIVE VALUE OF CA-125 FOR OVARIAN-CARCINOMA IN PATIENTS PRESENTING WITH PELVIC MASSES - REPLY
    OCONNEL, G
    MURPHY, KJ
    OBSTETRICS AND GYNECOLOGY, 1988, 71 (06): : 949 - 950
  • [43] SAVINGS OBTAINED BY CA-125 MEASUREMENTS DURING THERAPY FOR OVARIAN-CARCINOMA
    RUSTIN, GJS
    NELSTROP, A
    STILWELL, J
    LAMBERT, HE
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) : 79 - 82
  • [44] CA-125 DETECTION IN ABDOMINAL LAVAGE LIQUID AND IN ASCITES IN OVARIAN-CARCINOMA
    MEIER, W
    STIEBER, P
    FATEHMOGHADAM, A
    EIERMANN, W
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 376 - 376
  • [45] Effect of topotecan on serum CA-125 in patients with advanced epithelial ovarian cancer
    Nielsen, HA
    Nielsen, D
    Engelholm, SA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 383 - 388
  • [46] Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer
    Colakovic, S
    Lukiç, V
    Mitroviç, L
    Jeliç, S
    Susnjar, S
    Marinkoviç, J
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (02): : 147 - 152
  • [47] AN INDEPENDENT EVALUATION OF THE POTENTIAL CLINICAL USEFULNESS OF PROPOSED CA-125 INDEXES PREVIOUSLY SHOWN TO BE OF PROGNOSTIC-SIGNIFICANCE IN EPITHELIAL OVARIAN-CANCER
    CRUICKSHANK, DJ
    PAUL, J
    LEWIS, CR
    MCALLISTER, EJ
    KAYE, SB
    BRITISH JOURNAL OF CANCER, 1992, 65 (04) : 597 - 600
  • [48] THE MANAGEMENT OF OVARIAN-CARCINOMA IS IMPROVED BY THE USE OF CANCER-ASSOCIATED SERUM ANTIGEN AND CA-125 ASSAYS
    WARD, BG
    MCGUCKIN, MA
    RAMM, LE
    COGLAN, M
    SANDERSON, B
    TRIPCONY, L
    FREE, KE
    CANCER, 1993, 71 (02) : 430 - 438
  • [49] THE PROGNOSTIC VALUE OF SERUM CA-125 IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - AN ANALYSIS OF 573 PATIENTS BY THE MEDICAL-RESEARCH-COUNCIL WORKING PARTY ON GYNECOLOGICAL CANCER
    FAYERS, PM
    RUSTIN, G
    WOOD, R
    NELSTROP, A
    LEONARD, RCF
    WILKINSON, P
    CRUICKSHANK, D
    MCALLISTER, EJ
    REDMAN, CWE
    PARKER, D
    SCOTT, IV
    SLEVIN, ML
    ROULSTON, JE
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (05) : 285 - 292
  • [50] PROGNOSTIC-SIGNIFICANCE OF EARLY SERUM TUMOR-MARKER HALF-LIFE IN METASTATIC TESTICULAR TERATOMA
    STEVENS, MJ
    NORMAN, AR
    DEARNALEY, DP
    HORWICH, A
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 87 - 92
12345